Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jan 07, 2026

SELL
$27.69 - $37.91 $1,412 - $1,933
-51 Closed
0 $0
Q1 2025

Jan 07, 2026

BUY
$31.43 - $39.7 $1,602 - $2,024
51 New
51 $1.73 Million
Q4 2024

Jan 07, 2026

BUY
$32.49 - $50.28 $1,656 - $2,564
51 New
51 $1.66 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $5.07B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Aventura Private Wealth, LLC Portfolio

Follow Aventura Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aventura Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aventura Private Wealth, LLC with notifications on news.